There’s news too on our recently updated COVID-19 living systematic review, an open-access visual database of COVID-19 global registered trials which was developed in collaboration with the COVID-19 Clinical Research Coalition.
Other highlights include a memorandum of understanding signed with Indian authorities for a data and skill-sharing partnership between the Indian Council of Medical Research and IDDO; and the largest-ever malaria meta-analysis on pooled individual patient data involving over 70,000 patients recently published in BMC Medicine.
Our VL platform has also been very busy, publishing a series of systematic reviews which have identified a gender imbalance in clinical trials, insufficient reporting of serious adverse events and the underreporting of VL in pregnant women. The platform has also launched two study groups on anaemia among patients with VL and haematological dynamics post treatment, and host parasite and drug determinants of therapeutic responses.
Also featured in this latest newsletter are updates on our work on scrub typhus, Chagas disease, febrile illness and medicine quality.
Read the full newsletter.